INPLASY202160033

Comparison of PARP Inhibitors as Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

PARP inhibitor; ovarian cancer; maintenance therapy; network meta-analysis; progression-free survival; adverse reactions.

Download PDF - 202160033

Review Status: Completed and published